Frequency of Adrenal Insufficiency in Patients With Hypoglycemia in an Emergency Department: A Cross-sectional Study

Tetsuya Kawahara, Maiko Tsuji, Naoki Tominaga, Nagahiro Toyama, Mikio Toda, Tetsuya Kawahara, Maiko Tsuji, Naoki Tominaga, Nagahiro Toyama, Mikio Toda

Abstract

Context: In most patients presenting with hypoglycemia in emergency departments, the etiology of hypoglycemia is identified. However, it cannot be determined in approximately 10% of cases.

Objective: We aimed to identify the causes of unknown hypoglycemia, especially adrenal insufficiency.

Methods: In this cross-sectional study, we evaluated the etiology of hypoglycemia among patients in our emergency department with hypoglycemia (plasma glucose level < 70 mg/dL (3.9 mmol/L)] between April 1, 2016 and March 31, 2021 using a rapid adrenocorticotropic hormone (ACTH) test.

Results: There were 528 cases with hypoglycemia included [52.1% male; median age 62 years (range 19-92)]. The majority [389 (73.7%)] of patients were using antidiabetes drugs. Additionally, 33 (6.3%) consumed alcohol; 17 (3.2%) had malnutrition; 13 (2.5%), liver dysfunction; 12 (2.3%), severe infectious disease; 11 (2.1%), malignancy; 9 (1.7%), heart failure; 4 (0.8%), insulin autoimmune syndrome; 3 (0.6%), insulinoma; 2 (0.4%) were using hypoglycemia-relevant drugs; and 1 (0.2%) suffered from non-islet cell tumor. Rapid ACTH tests revealed adrenal insufficiency in 32 (6.1%). In those patients, serum sodium levels were lower (132 vs 139 mEq/L, P < 0.01), eosinophil counts were higher (14 vs 8%, P < 0.01), and systolic blood pressure was lower (120 vs 128 mmHg, P < 0.05) at baseline than in patients with the other etiologies.

Conclusion: The frequency of adrenal insufficiency as a cause of hypoglycemia was much higher than what we anticipated. When protracted hypoglycemia of unknown etiology is recognized, we recommend that the patient is checked for adrenal function using a rapid ACTH test.

Keywords: adrenal insufficiency; emergency department; hypoglycemia; rapid ACTH test.

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.

Figures

Figure 1.
Figure 1.
Study flow diagram.
Figure 2.
Figure 2.
Percentage of each etiology in patients with hypoglycemia. Out of 528 patients with hypoglycemia transported to our emergency department, 389 (73.7%) were on antidiabetes drugs; 35 (6.6%) had alcohol abuse problem; 32 (6.1%), adrenal insufficiency; 18 (3.4%), malnutrition; 15 (2.8%), liver dysfunction; 11 (2.1%), malignancy; 9 (1.7%), heart failure; 7 (1.3%), severe infection; 4 (0.8%), insulin antibody syndrome; 3 (0.6%), insulinoma; 2 (0.4%) were receiving hypoglycemia-related drugs; 2 (0.4%) had unknown etiology; and 1 (0.2%), non-islet cell tumor.

References

    1. Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol. 1985;17(5):421-430. doi:10.1002/ana.410170502
    1. Sako A, Yasunaga H, Matsui H, et al. . Hospitalization with hypoglycemia in patients without diabetes mellitus: a retrospective study using a national inpatient database in Japan, 2008-2012. Medicine (Baltim). 2017;96(25):e7271. doi:10.1097/MD.0000000000007271
    1. Nirantharakumar K, Marshall T, Hodson J, et al. . Hypoglycemia in non-diabetic in-patients: clinical or criminal? PLoS One. 2012;7(7):e40384. doi:10.1371/journal.pone.0040384
    1. Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab. 2009;94(4):1059-1067. doi:10.1210/jc.2009-0032
    1. Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335(16):1206-1212. doi:10.1056/NEJM199610173351607
    1. Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152-2167. doi:10.1016/S0140-6736(13)61684-0
    1. Erichsen MM, Lovas K, Skinningsrud B, et al. . Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab. 2009;94(12):4882-4890. doi:10.1210/jc.2009-1368
    1. Chakera AJ, Vaidya B. Addison disease in adults: diagnosis and management. Am J Med. 2010;123(5):409-413. doi:10.1016/j.amjmed.2009.12.017
    1. Takayanagi R. 3. Epidemiology of adrenal insufficiency. Nippon Naika Gakkai Zasshi. 2008;97(4):711-715. doi:10.2169/naika.97.711
    1. Yanase T, Tajima T, Katabami T, et al. . Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [opinion]. Endocr J. 2016;63(9):765-784. doi:10.1507/endocrj.EJ16-0242
    1. Lovas K, Husebye ES. High prevalence and increasing incidence of Addison’s disease in western Norway. Clin Endocrinol (Oxf). 2002;56(6):787-791. doi:10.1046/j.1365-2265.2002.t01-1-01552.x
    1. Meyer G, Neumann K, Badenhoop K, Linder R. Increasing prevalence of Addison’s disease in German females: health insurance data 2008-2012. Eur J Endocrinol. 2014;170(3):367-373. doi:10.1530/EJE-13-0756
    1. Kong MF, Jeffcoate W. Eighty-six cases of Addison’s disease. Clin Endocrinol (Oxf). 1994;41(6):757-761. doi:10.1111/j.1365-2265.1994.tb02790.x
    1. Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361(9372):1881-1893. doi:10.1016/S0140-6736(03)13492-7
    1. Tomlinson JW, Holden N, Hills RK, et al. ; West Midlands Prospective Hypopituitary Study Group. Association between premature mortality and hypopituitarism. Lancet. 2001;357(9254):425-431. doi:10.1016/s0140-6736(00)04006-x
    1. Hahner S, Loeffler M, Bleicken B, et al. . Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol. 2010;162(3):597-602. doi:10.1530/EJE-09-0884
    1. Regal M, Paramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001;55(6):735-740. doi:10.1046/j.1365-2265.2001.01406.x
    1. Woods CP, Argese N, Chapman M, et al. . Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol. 2015;173(5):633-642. doi:10.1530/EJE-15-0608
    1. Kumar R, Wassif WS. Adrenal insufficiency. J Clin Pathol. 2022;75(7):435-442. doi:10.1136/jclinpath-2021-207895
    1. Annane D, Pastores SM, Rochwerg B, et al. . Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017;45(12):2078-2088. doi:10.1097/CCM.0000000000002737
    1. Bornstein SR, Allolio B, Arlt W, et al. . Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. doi:10.1210/jc.2015-1710
    1. Jang CW, Kim YK, Kim KH, Chiara A, Lee MS, Bae JH. Predictors for high-risk carotid plaque in asymptomatic Korean population. Cardiovasc Ther. 2020;2020:6617506. doi:10.1155/2020/6617506
    1. Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2010;39(3):641-654. doi:10.1016/j.ecl.2010.05.003
    1. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50(6):1140-1147. doi:10.1007/s00125-007-0599-y
    1. Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf. 2010;9(5):675-681. doi:10.1517/14740338.2010.492777
    1. Donnelly LA, Morris AD, Frier BM, et al. . Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med. 2005;22(6):749-755. doi:10.1111/j.1464-5491.2005.01501.x
    1. Cryer PE, Axelrod L, Grossman AB, et al. . Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709-728. doi:10.1210/jc.2008-1410
    1. Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am. 1999;28(3):555-577. doi:10.1016/s0889-8529(05)70088-8
    1. Yamamoto T, Fukuyama J, Hasegawa K, Sugiura M. Isolated corticotropin deficiency in adults: report of 10 cases and review of literature. Arch Intern Med. 1992;152(8):1705-1712.
    1. Burke CW. Adrenocortical insufficiency. Clin Endocrinol Metab. 1985;14(4):947-976. doi:10.1016/s0300-595x(85)80084-0.
    1. Stacpoole PW, Interlandi JW, Nicholson WE, Rabin D. Isolated ACTH deficiency: a heterogeneous disorder: critical review and report of four new cases. Medicine (Baltim). 1982;61(1):13-24.
    1. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87(6):457-461. doi:10.1136/adc.87.6.457
    1. Mah PM, Jenkins RC, Rostami-Hodjegan A, et al. . Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf). 2004;61(3):367-375. doi:10.1111/j.1365-2265.2004.02106.x
    1. Annane D, Bellissant E, Sebille V, et al. . Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol. 1998;46(6):589-597. doi:10.1046/j.1365-2125.1998.00833.x
    1. Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015;3(3):216-226. doi:10.1016/S2213-8587(14)70142-1
    1. Feldman RD, Gros R. Vascular effects of aldosterone: sorting out the receptors and the ligands. Clin Exp Pharmacol Physiol. 2013;40(12):916-921. doi:10.1111/1440-1681.12157
    1. Cuesta M, Garrahy A, Slattery D, et al. . The contribution of undiagnosed adrenal insufficiency to euvolaemic hyponatraemia: results of a large prospective single-centre study. Clin Endocrinol (Oxf). 2016;85(6):836-844. doi:10.1111/cen.13128
    1. Letizia C, Cerci S, Centanni M, et al. . Circulating levels of adrenomedullin in patients with Addison’s disease before and after corticosteroid treatment. Clin Endocrinol (Oxf). 1998;48(2):145-148. doi:10.1046/j.1365-2265.1998.3531170.x
    1. Zuckerman-Levin N, Tiosano D, Eisenhofer G, Bornstein S, Hochberg Z. The importance of adrenocortical glucocorticoids for adrenomedullary and physiological response to stress: a study in isolated glucocorticoid deficiency. J Clin Endocrinol Metab. 2001;86(12):5920-5924. doi:10.1210/jcem.86.12.8106
    1. Thorn GW, Forsham PH, et al. . A test for adrenal cortical insufficiency; the response to pituitary andrenocorticotropic hormone. J Am Med Assoc. 1948;137(12):1005-1009. doi:10.1001/jama.1948.02890460001001
    1. Oboni JB, Marques-Vidal P, Pralong F, Waeber G. Predictive factors of adrenal insufficiency in patients admitted to acute medical wards: a case control study. BMC Endocr Disord. 2013;13:3. doi:10.1186/1472-6823-13-3
    1. Spry C. Eosinophilia in Addison’s disease. Yale J Biol Med. 1976;49(4):411-413.
    1. Skiest DJ, Keiser P. Clinical significance of eosinophilia in HIV-infected individuals. Am J Med. 1997;102(5):449-453. doi:10.1016/S0002-9343(97)00048-X
    1. Alsahli M, Gerich JE. Hypoglycemia, chronic kidney disease, and diabetes mellitus. Mayo Clin Proc. 2014;89(11):1564-1571. doi:10.1016/j.mayocp.2014.07.013
    1. Busch M, Lehmann T, Wolf G, Gunster C, Muller UA, Muller N. Antidiabetic therapy and rate of severe hypoglycaemia in patients with type 2 diabetes and chronic kidney disease of different stages: a follow-up analysis of health insurance data from Germany. Exp Clin Endocrinol Diabetes. 2021;129(11):821-830. doi:10.1055/a-1129-6699
    1. Moen MF, Zhan M, Hsu VD, et al. . Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1121-1127. doi:10.2215/CJN.00800209
    1. Ahmad I, Zelnick LR, Batacchi Z, et al. . Hypoglycemia in people with type 2 diabetes and CKD. Clin J Am Soc Nephrol. 2019;14(6):844-853. doi:10.2215/CJN.11650918

Source: PubMed

3
Prenumerera